drugset / Trial / NCT04844840
A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence
RandomizedParallel-groupDouble-blindTreatment
Summary
Phase 2, randomized, double-blind, multiple arm, controlled study to evaluate safety \& efficacy of various doses of STP705 in reducing post Keloidectomy keloid recurrence.
Timeline
- Start
- 2021-04-29
- Primary completion
- 2023-05-17
- Completion
- 2023-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STP705 | Small interfering RNA (siRNA) | 10 ug | Other |
| Subject | STP705 | Small interfering RNA (siRNA) | 20 ug | Other |
| Subject | STP705 | Small interfering RNA (siRNA) | 30 ug | Other |
| Subject | STP705 | Small interfering RNA (siRNA) | 40 ug | Other |